Araştırma Makalesi

Hipertansiyon prevelansı ve ilişkili uç organ hasarı ;retrospektif tek merkez deneyimi

Cilt: 63 Sayı: 4 9 Aralık 2024
PDF İndir
EN TR

Hypertension prevalence and connected end organ damage: a retrospective single center experience

Abstract

Objective: Hypertension (HT) is the most commonly altered risk factor for stroke, myocardial infarction, congestive heart failure, peripheral vascular disease and end-stage kidney disease. The prevalence of hypertension has been consistently reported in numerous epidemiological studies. It has been determined as 25-55% in adult population samples in most industrialized countries. In our study in our Internal Diseases outpatient clinic, we aimed to determine the prevalence of hypertension and the rates of end organ damage in patients who applied to our outpatient clinic. Methods: Biochemical tests and consultation notes of patients who applied to the Ege University Medical Faculty Hospital Internal Diseases Policlinic between August 2018 and March 2019 were analyzed retrospectively through the Electronic Patient File. Data related to hypertension related end organ damage such as age, gender, smoking, city of residence, antihypertensive drugs used, additional diseases, biochemical data, spot urine and full urine examination, ECG, fundoscopic examination were examined. SPSS 25.0 program was used for statistical analysis. Results: A total of 1267 patients who applied to our outpatient clinic between these dates were included in the study. Of these, 332 people were hypertensive, 935 were normotensive, and two groups were formed. The prevalence of hypertension was 26.2%, and the incidence of six months hypertension was 12.5%. 65% of the patients were female and the mean age was 57 ± 14. 40% of the cases were patients diagnosed in the outpatient clinic during blood pressure measurement. According to Sokolow Lyon criteria, 12.3% of patients had left ventricular hypertrophy in the ECG s that was examined regarding hypertension related end organ injury. Proteinuria rate was 23% according to spot urine data. The rate of hypertensive retinopathy was 32.85%. A close correlation was found between hypertensive retinopathy and the frequency of cerebrovascular events. It was found that the frequency of hypertensive retinopathy increased significantly in hypertensive patients with high serum total cholesterol level. Conclusions: We found a positive correlation between hypertensive retinopathy and SVO frequency. We found a positive correlation between hypertension-associated LVH and hypertensive retinopathy. We think that fundoscopic examination, 12-lead ECG, spot urine protein / creatinine ratio tests should be performed regularly in all hypertensive patients. In this way, secondary diseases caused by hypertension can be prevented. We found a close relationship between serum total cholesterol elevationand the development of retinopathy. Starting the necessary treatment early by monitoring the lipid levels of all hypertensive patients may prevent the development of retinopathy.

Keywords

Proje Numarası

1

Teşekkür

İç Hastalıkları asistanlık eğitimim süresince bana her zaman desteklerini sunan İç Hastalıkları Anabilim Dalı başkanı Sn. Prof. Dr. S. Fehmi Akçiçek’e Asistanlık eğitimim ve tezimin hazırlanması süresince engin bilgi birikimi ve bilimsel deneyimiyle bana her daim yol gösterici olan, bilimsel araştırmalara olan ilgimin artmasını sağlayan tez danışmanım Sn. Prof. Dr. Soner Duman’a teşekkürü borç bilirim.

Kaynakça

  1. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. Journal of hypertension. 2016;34(6):1208-17.
  2. Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü, Abacı A, et al. Türk hipertansiyon uzlaşı raporu 2019. Turk Kardiyol Dern Ars. 2019;47(6):535-46.
  3. Seyahi N, Ateş K, Süleymanlar G. Current status of renal replacement therapy in Turkey: A summary of the Turkish society of nephrology registry report. Current Status of Renal Replacement Therapy in Turkey. 2020.
  4. Bergler-Klein J. What’s new in the ESC 2018 guidelines for arterial hypertension: The ten most important messages. Wiener Klinische Wochenschrift. 2019;131(7-8):180-5.
  5. Rakotovao-Ravahatra ZD, Randriatsarafara FM, Razafimanantsoa F, Rabetokotany FR, Rakotovao AL. Blood count results from hypertensive patients seen in laboratory of CHU-HJRB Antananarivo in 2013. The Pan African Medical Journal. 2016;23:49-.
  6. Bozduman F, Yildirim E, Cicek G. Biomarkers of nondipper hypertension in prehypertensive and hypertensive patients. Biomarkers in Medicine. 2019;13(05):371-8.
  7. Cetin N, Tufan AK. Platelet activation and inflammation in hypertensive children with non-dipper and dipper status. Iranian journal of kidney diseases. 2019;13(2):105.
  8. Erdogan D, Icli A, Aksoy F, Akcay S, Ozaydin M, Ersoy I, et al. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure. Chronobiology International. 2013;30(8):973-80.

Ayrıntılar

Birincil Dil

Türkçe

Konular

İç Hastalıkları

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

9 Aralık 2024

Gönderilme Tarihi

17 Kasım 2023

Kabul Tarihi

14 Ağustos 2024

Yayımlandığı Sayı

Yıl 1970 Cilt: 63 Sayı: 4

Kaynak Göster

Vancouver
1.Oğuzcan Özkan, Soner Duman. Hipertansiyon prevelansı ve ilişkili uç organ hasarı ;retrospektif tek merkez deneyimi. ETD. 01 Aralık 2024;63(4):543-52. doi:10.19161/etd.1392585

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.